Hormones and pregnancy

International MS Journal

Volumn 10, Issue 2, 2003, Pages 35-36

  Duquette, Pierre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRIOL; ESTROGEN; GADOLINIUM; GAMMA INTERFERON; HORMONE; PROGESTERONE;

AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; COLON CANCER; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; HORMONE SUBSTITUTION; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; OSTEOPOROSIS; PARENT COUNSELING; PREGNANCY; REVIEW; SEX CHROMOSOME; SEX RATIO; SJOEGREN SYNDROME; UTERUS CANCER;

EID: 0038512228     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C. The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992; 19: 466-471.
2. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group (see comments). N Engl J Med 1998; 339: 285-291.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321-333.